Filing Details

Accession Number:
0000950170-24-044538
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-15 18:27:12
Reporting Period:
2024-04-11
Accepted Time:
2024-04-15 18:27:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1816736 Disc Medicine Inc. IRON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1778739 Richard William White C/O Disc Medicine, Inc.
321 Arsenal Street, Suite 101
Watertown MA 02472
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-11 1,756 $2.65 1,756 No 4 M Direct
Common Stock Acquisiton 2024-04-11 804 $9.86 2,560 No 4 M Direct
Common Stock Disposition 2024-04-11 2,482 $31.79 78 No 4 S Direct
Common Stock Disposition 2024-04-11 78 $32.18 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-04-11 1,756 $0.00 1,756 $2.65
Common Stock Stock Option (Right to Buy) Disposition 2024-04-11 804 $0.00 804 $9.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,268 2030-11-26 No 4 M Direct
3,412 2031-09-13 No 4 M Direct
Footnotes
  1. The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on December 13, 2023.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.1178 to $32.1005, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.1247 to $32.3048, inclusive.
  4. The shares underlying this option vest in 16 equal quarterly installments following November 27, 2020, subject to the Reporting Person's continued service on each such vesting date.
  5. The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.